However, it has been demonstrated that the short form of PRDM16 (sPRDM16-exon1) promote leukemia development and progression by stimulating cell growth and inhibiting differentiation of AML cells both in vitro and in vivo (17). The gene discussed is PRDM16; the disease is leukemia.